Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States

Emerging Infectious Diseases

Volumn 20, Issue 5, 2014, Pages 822-828

  Steinau, Martin ^a   Saraiya, Mona ^a   Goodman, Marc T ^b   Peters, Edward S ^c   Watson, Meg ^a   Cleveland, Jennifer L ^a   Lynch, Charles F ^d   Wilkinson, Edward J ^e   Hernandez, Brenda Y ^f   Copeland, Glen ^g   Saber, Maria S ^h   Hopenhayn, Claudia ⁱ   Huang, Youjie ^j   Cozen, Wendy ^g   Lyu, Christopher ^k   Unger, Elizabeth R ^a   Ellis, Bruce ^g   Madero, Natalie ^g   Reid, Emily ^g   Little, Donna ^g   Greek, April ^g   Rhoda, Dale ^g   Gieseke, Linda Delma ^g   Ashcraft, Stephanie ^g   Gideon, Katherine ^k   Ruhlen, Tara ^l   Scarbrough, Mariela Z ^a   Thompson, Trevor ^a   Datta, Deblina ^a   Hariri, Susan ^a   Cole, Lauren ^c   Ashley, Lana ^m   Alverson, Jetty ^m   Hulbert, Michelle ^m   Silva, Won ^m   Altekruse, Sean ⁿ   Hirsch, Samuel ^o   Campbell Thompson, Martha ^e   Wright, Amy ^e   Durden, Kelley ^e   MacKinnon, Jill ^p   Alvarez, Carlos ^p   Luk, Hugh ^q   Horio, David ^q   Ikeda, Shoji ^q   Green, Michael ^q   Grafel Anderson, Catherine ^q   Weise, Rayna ^q   Selk, Freda ^d   Olson, Dan ^d   Tucker, Thomas ⁱ   Christian, Amy ⁱ   Brossoie, Susan ^r   House, Joe ^s   Cockburn, Myles G ^s   Kim, Andre ^s   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY OF FLORIDA   (United States)

^f UNIVERSITY OF HAWAII   (United States)

^g Los Angeles Cancer Registry ^*

^h Queen Angels Hollywood Presbyt Med   (United States)

ⁱ UNIVERSITY OF KENTUCKY   (United States)

^j FLORIDA DEPARTMENT OF HEALTH   (United States)

^k BATTELLE MEMORIAL INSTITUTE   (United States)

^l Carolinas Rehabilitation   (United States)

^m MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

ⁿ NATIONAL CANCER INSTITUTE   (United States)

^o ST JOSEPH MERCY HOSPITAL   (United States)

^p UNIVERSITY OF MIAMI   (United States)

^q UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^r UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^s UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADULT; AGED; ARTICLE; CANCER PREVENTION; ETHNICITY; FEMALE; GENDER; GENOTYPING TECHNIQUE; HISPANIC; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; VIRUS TYPING; WART VIRUS; ALPHAPAPILLOMAVIRUS; CLASSIFICATION; EPIDEMIOLOGY; HEALTH SURVEY; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; REGISTER; UNITED STATES; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; FEMALE; HUMANS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREVALENCE; PUBLIC HEALTH SURVEILLANCE; REGISTRIES; UNITED STATES;

EID: 84898847873     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2005.131311     Document Type: Article

References (33)

1. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13:607-15. http://dx.doi.org/10.1016/S1470-2045(12)70137-7
2. Centers for Disease Control and Prevention (CDC). Human papillomavirus-associated cancers-United States, 2004-2008. MMWR Morb Mortal Wkly Rep. 2012;61:258-61.
3. Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic clinical, and molecular entity. Semin Oncol. 2004;31:744-54. http://dx.doi.org/10.1053/j.seminoncol.2004.09.011
4. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944-56. http://dx.doi.org/10.1056/NEJMoa065497
5. Martinez I, Wang J, Hopson KF, Ferris RL, Khan SA. Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas. Eur J Cancer. 2007;43:415-32. http://dx.doi.org/10.1016/j.ejca.2006.09.001
6. Miller DL, Puricelli MD, Stack MS. Virology and molecular pathogenesis of HPV (human papillomovirus)-associated oropharyngeal squamous cell carcinoma. Biochem J. 2012;443:339-53. http://dx.doi.org/10.1042/BJ20112017
7. Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki HA, et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after HPV vaccination in a randomized clinical trial in Costa Rica. PLoS ONE. 2013;8:e68329. http://dx.doi.org/10.1371/journal. pone.0068329
8. Watson M, Saraiya M, Ahmed F, Cardinez CJ, Reichman ME, Weir HK, et al. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods. Cancer. 2008;113 (Suppl):2841-54. http://dx.doi.org/10.1002/cncr.23758
9. Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer. 2008;113:3036-46. http://dx.doi.org/10.1002/ cncr.23764
10. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261-9. http://dx.doi.org/10.1093/ jnci/djn011
11. Kreimer AR, Clifford GM, Boyle PB, Fransceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14:467-75. http://dx.doi.org/10.1158/1055-9965. EPI-04-0551
12. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294-301. http://dx.doi.org/10.1200/JCO.2011.36.4596
13. Ryerson AB, Peters ES, Caughlin SS, Chen VW, Gillison ML, Reichman ME, et al. Burden of potentially human papillomavirusassociated cancer of the oropharynx and oral cavity in the US, 1998-2003. Cancer. 2008;113:2901-9. http://dx.doi.org/10.1002/cncr.23745
14. Mirghani H, Moreau F, Lefèvre M, Tam C, Périé S, Soussan P, et al. Human papillomavirus type 16 oropharyngeal cancer in lymph nodes as a marker of metastases. Arch Otolaryngol Head Neck Surg. 2011;137:910-4. http://dx.doi.org/10.1001/archoto.2011.141
15. Gargano JW, Wilkinson EJ, Unger ER, Steinau M, Watson M, Huang Y, et al. Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction. J Low Genit Tract Dis. 2012;16:471-9. http://dx.doi.org/10.1097/ LGT.0b013e3182472947
16. Steinau M, Unger ER, Hernandez BY, Goodman MT, Copeland G, Hopenhayn C, et al. Human papillomavirus prevalence in invasive anal cancers in the United States prior to vaccine introduction. J Low Genit Tract Dis. 2013; 17:397-403. http://dx.doi.org/10.1097/ LGT.0b013e31827ed372
17. Steinau M, Patel SS, Unger ER. Efficient DNA extraction for HPV genotyping in formalin-fixed, paraffin-embedded tissues. J Mol Diagn. 2011;13:377-81. http://dx.doi.org/10.1016/j. jmoldx.2011.03.007
18. Hariri S, Steinau M, Rinas A, Gargano J, Ludema C, Unger ER, et al. HPV genotyping in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006. PLoS ONE. 2012;7:e34044. http://dx.doi.org/10.1371/journal.pone.0034044
19. Steinau M, Onyekwuluje JM, Scarbrough MZ, Unger ER, Dillner J, Zhou T. Performance of commercial reverse line blot assays for human papillomavirus genotyping. J Clin Microbiol. 2012;50:1539-44. http://dx.doi.org/10.1128/JCM.06576-11
20. Onyekwuluje JM, Steinau M, Swan DC, Unger ER. A real time PCR assay for HPV52 detection and viral load quantification. Clin Lab. 2012;58:61-6.
21. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah K, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-9. http://dx.doi.org/10.1002/(SICI)1096-9896(199909)189:1<12: AID-PATH431>3.0.CO;2-F
22. Watson M, Lyu C, Unger ER, Copeland G, Peters E, Huang Y, et al. Centers for Disease Control and Prevention human papillomavirus typing of cancers study with 7 registries: evaluating representativeness. North American Association of Central Cancer Registries (NAACCR) Annual Conference, 2011. Abstract, no. 58. http://www.naaccr.org/LinkClick.aspx?fileticket=udtv3Esreek%3d &tabid=257&mid=732
23. Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck. 2013;35:747-55. http://dx.doi.org/10.1002/hed.22015
24. Frisch M, Hjalgrim H, Jaeger AB, Biggar RJ. Changing patterns of tonisllar squamous cell carcinoma in the United States. Cancer Causes Control. 2000;11:489-95. http://dx.doi.org/10.1023/A: 1008918223334
25. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45:309-16. http://dx.doi.org/10.1016/ j.oraloncology.2008.06.002
26. Paolini F, Rizzo C, Sperduti I, Pichi B, Mafera B, Rahimi SS, et al. Both mucosal and cutaneous papillomaviruses are in the oral cavity but only alpha genus seems to be associated with cancer. J Clin Virol 2013;56:72-6 http://dx.doi.org/10.1016/j.jcv.2012.09.016
27. Gillison ML, Broutian T, Pickard RK, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA. 2012;307:693-703. http://dx.doi.org/10.1001/jama.2012.101
28. Brown LM, Check DP, Devesa SS. Oropharyngeal cancer incidence trends: diminishing disparities. Cancer Causes Control. 2011;22:753-63. http://dx.doi.org/10.1007/s10552-011-9748-1
29. Settle K, Posner MR, Schumaker LM, Tan M, Suntharalingam M, Goloubeva O, et al. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila). 2009;2:776-81. http://dx.doi.org/10.1158/1940-6207.CAPR-09-0149
30. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and-unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26:612-9. http://dx.doi.org/10.1200/JCO.2007.14.1713
31. Pai SI, Westra WH. Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu Rev Pathol. 2009;4:49-70. http://dx.doi.org/10.1146/annurev. pathol.4.110807.092158
32. Jung AC, Briolat J, Millon R, de Reyniès A, Rickman D, Thomas E, et al. Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. Int J Cancer. 2010;126:1882-94. http://dx.doi. org/10.1002/ijc.24911
33. Sethi S, Ali-Fehmi R, Franceschi S, Struijk L, van Doorn L-J, Quint W, et al. Characteristics and survival of head and neck cancer by HPV status: a cancer registry-based study. Int J Cancer. 2012;131:1179-86. http://dx.doi.org/10.1002/ijc.26500